Godavari Biorefineries Limited — PPTs, 25-05-2025: Investor Presentation

1. Financial Highlights:

Godavari Biorefineries posted Q4 revenue of ₹579.5 Cr, down 5.8% YoY, with EBITDA at ₹121.7 Cr (21% margin) and PAT at ₹96.4 Cr (16.6% margin), maintaining strong profitability despite softer sales. FY25 revenue rose 10.8% to ₹1,870.3 Cr, though EBITDA margin narrowed to 6.4% and PAT was marginal at ₹1.1 Cr due to seasonality and cost pressures. The company reduced term debt by ₹240 Cr, cutting finance costs by about one-third. Total assets stand at ₹1,955 Cr with borrowings lowered to ₹489 Cr, reflecting a healthier balance sheet.

2. Strategic Initiatives & Growth Drivers:

Record sugarcane crushing at Sameerwadi (24.65 lakh tons) boosted operational efficiency. The 200 KLPD grain/maize distillery remains on track for commercial production by Q4 FY26, supporting expanded ethanol output. Focused efforts on debottlenecking bio-based chemicals and growing specialty chemicals aim to drive higher margins with an emphasis on sustainable, green chemistry-based growth.

3. Business Developments:

Revenue from bio-based specialty chemicals grew 28% YoY in Q4, driven by a shift to higher-margin products. Ethanol production scaled up to 45,042 KL, benefiting from diversified feedstock including cane and molasses. Progress continues on cancer drug research targeting triple-negative breast cancer, with safety trials expected to conclude by Q2 FY26.

4. Market Position & Competitive Advantage:

Godavari Biorefineries leverages one of India’s largest sugarcane crushing operations and a leading bio-based specialty chemicals portfolio. Its integrated footprint across sugar, ethanol, and chemicals provides scale, flexibility, and a strong footing to capitalize on India’s green energy and bio-chemicals market expansion.

5. Investor Implications:

Debt reduction and capacity expansions underline healthy momentum and positive growth potential, especially in specialty chemicals and ethanol segments. Investors should watch for execution risks linked to seasonal volumes and ethanol pricing but the company is well positioned to benefit from accelerating bio-economy and sustainability trends.